4 Trademark Results found for "GENOR*"

Also try searching for:

GENO*

*NOR

GE*OR

Details	Status	Class/Description
GENORA S.P.H. - GERARD BERTRAND 2149699 5 Oct 2021	REGISTERED on 18 Oct 2023	Vins. Class 033 Class 033 Wines and Spirits Products Vins.
GENORUM FUMEI SHEN 2039802 15 Jul 2020	REGISTERED on 8 Feb 2023	Ballet slippers; bath slippers; dress shoes; gloves; hats; leather sli... Class 025 Class 025 Clothing Products Ballet slippers; bath slippers; dress shoes; gloves; hats; leather slippers; pedicure slippers; shoes; slipper socks; slippers.
GENOR GENOR BIOPHARMA CO. LTD. 1444812 15 Jul 2009	REGISTERED on 28 Feb 2013	Pharmaceutical advice.,Treatment of materials for the manufacturing of... Class 001 Class 001 Chemical Products Class 005 Class 005 Pharmaceutical Products Biological preparations for pharmaceutical purposes for the treatment of hepatitis A, inflammatory diseases, namely, inflammatory bowel diseases, inflammatory connective tissue diseases, blood disorders, nutritional disorders, namely, mineral deficiency and toxicity, obesity, metabolic syndrome, under nutrition, vitamin deficiency, dependency and toxicity, immunological diseases, namely, autoimmune diseases, immunologic deficiency syndromes, dermatological disorders, namely, dermatitis, skin pigmentation diseases, sexually transmitted diseases, genetic disorders, namely, lysosomal storage diseases, mucopolysaccharidoses, phenylketonuria, alpha-mannosidosis, cystic fibrosis and muscular dystrophy, neurodegenerative diseases, namely, anxiety, depression, sleep disorders, chronic fatigue, schizophrenia, epilepsy, viral diseases, namely, herpes, hepatitis, Acquired Immune Deficiency Syndrome (AIDS), and infectious diseases, namely, respiratory infections, eye infections, antiparasites, cancer, obesity and diabetes in humans; sanitary preparations for medical use in the treatment of hepatitis A, inflammatory diseases, namely, inflammatory bowel diseases, inflammatory connective tissue diseases, blood disorders, nutritional disorders, namely, mineral deficiency and toxicity, obesity, metabolic syndrome, under nutrition, vitamin deficiency, dependency and toxicity, immunological diseases, namely, autoimmune diseases, immunologic deficiency syndromes, dermatological disorders, namely, dermatitis, skin pigmentation diseases, sexually transmitted diseases, genetic disorders, namely, lysosomal storage diseases, mucopolysaccharidoses, phenylketonuria, alpha-mannosidosis, cystic fibrosis and muscular dystrophy, neurodegenerative diseases, namely, anxiety, depression, sleep disorders, chronic fatigue, schizophrenia, epilepsy, viral diseases, namely, herpes, hepatitis, Acquired Immune Deficiency Syndrome (AIDS), and infectious diseases, namely, respiratory infections, eye infections, antiparasites, cancer, obesity and diabetes in humans; medicines for treatment of viral and bacterial infections, namely, hepatitis A, inflammatory diseases, namely, inflammatory bowel diseases, inflammatory connective tissue diseases, blood disorders, nutritional disorders, namely, mineral deficiency and toxicity, obesity, metabolic syndrome, under nutrition, vitamin deficiency, dependency and toxicity, immunological diseases, namely, autoimmune diseases, immunologic deficiency syndromes, dermatological disorders, namely, dermatitis, skin pigmentation diseases, sexually transmitted diseases, genetic disorders, namely, lysosomal storage diseases, mucopolysaccharidoses, phenylketonuria, alpha-mannosidosis, cystic fibrosis and muscular dystrophy, neurodegenerative diseases, namely, anxiety, depression, sleep disorders, chronic fatigue, schizophrenia, epilepsy, viral diseases, namely, herpes, hepatitis, Acquired Immune Deficiency Syndrome (AIDS), and infectious diseases, namely, respiratory infections, eye infections, antiparasites, cancer, obesity and diabetes in humans; active pharmaceutical ingredients for the treatment of viral and bacterial infections, namely, hepatitis A, inflammatory diseases, namely, inflammatory bowel diseases, inflammatory connective tissue diseases, blood disorders, nutritional disorders, namely, mineral deficiency and toxicity, obesity, metabolic syndrome, under nutrition, vitamin deficiency, dependency and toxicity, immunological diseases, namely, autoimmune diseases, immunologic deficiency syndromes, dermatological disorders, namely, dermatitis, skin pigmentation diseases, sexually transmitted diseases, genetic disorders, namely, lysosomal storage diseases, mucopolysaccharidoses, phenylketonuria, alpha-mannosidosis, cystic fibrosis and muscular dystrophy, neurodegenerative diseases, namely, anxiety, depression, sleep disorders, chronic fatigue, schizophrenia, epilepsy, viral diseases, namely, herpes, hepatitis, Acquired Immune Deficiency Syndrome (AIDS), and infectious diseases, namely, respiratory infections, eye infections, antiparasites, cancer, obesity and diabetes in humans; biological substances and preparations for medical use and purposed for the treatment of viral and bacterial infections, namely, hepatitis A, inflammatory diseases, namely, inflammatory bowel diseases, inflammatory connective tissue diseases, blood disorders, nutritional disorders, namely, mineral deficiency and toxicity, obesity, metabolic syndrome, under nutrition, vitamin deficiency, dependency and toxicity, immunological diseases, namely, autoimmune diseases, immunologic deficiency syndromes, dermatological disorders, namely, dermatitis, skin pigmentation diseases, sexually transmitted diseases, genetic disorders, namely, lysosomal storage diseases, mucopolysaccharidoses, phenylketonuria, alpha-mannosidosis, cystic fibrosis and muscular dystrophy, neurodegenerative diseases, namely, anxiety, depression, sleep disorders, chronic fatigue, schizophrenia, epilepsy, viral diseases, namely, herpes, hepatitis, Acquired Immune Deficiency Syndrome (AIDS), and infectious diseases, namely, respiratory infections, eye infections, antiparasites, cancer, obesity and diabetes in humans; human vaccines; monoclonal antibodies; recombinant pharmaceuticals for the treatment of viral and bacterial infections, namely, hepatitis A, inflammatory diseases, namely, inflammatory bowel diseases, inflammatory connective tissue diseases, blood disorders, nutritional disorders, namely, mineral deficiency and toxicity, obesity, metabolic syndrome, under nutrition, vitamin deficiency, dependency and toxicity, immunological diseases, namely, autoimmune diseases, immunologic deficiency syndromes, dermatological disorders, namely, dermatitis, skin pigmentation diseases, sexually transmitted diseases, genetic disorders, namely, lysosomal storage diseases, mucopolysaccharidoses, phenylketonuria, alpha-mannosidosis, cystic fibrosis and muscular dystrophy, neurodegenerative diseases, namely, anxiety, depression, sleep disorders, chronic fatigue, schizophrenia, epilepsy, viral diseases, namely, herpes, hepatitis, Acquired Immune Deficiency Syndrome (AIDS), and infectious diseases, namely, respiratory infections, eye infections, antiparasites, cancer, obesity and diabetes in humans; protein for use as an additive for medical/pharmaceutical preparations for human consumption [adapted for medical purposes] for the treatment of viral and bacterial infections, namely, hepatitis A, inflammatory diseases, namely, inflammatory bowel diseases, inflammatory connective tissue diseases, blood disorders, nutritional disorders, namely, mineral deficiency and toxicity, obesity, metabolic syndrome, under nutrition, vitamin deficiency, dependency and toxicity, immunological diseases, namely, autoimmune diseases, immunologic deficiency syndromes, dermatological disorders, namely, dermatitis, skin pigmentation diseases, sexually transmitted diseases, genetic disorders, namely, lysosomal storage diseases, mucopolysaccharidoses, phenylketonuria, alpha-mannosidosis, cystic fibrosis and muscular dystrophy, neurodegenerative diseases, namely, anxiety, depression, sleep disorders, chronic fatigue, schizophrenia, epilepsy, viral diseases, namely, herpes, hepatitis, Acquired Immune Deficiency Syndrome (AIDS), and infectious diseases, namely, respiratory infections, eye infections, antiparasites, cancer, obesity and diabetes in humans; and biotechnological preparations for medical use for the treatment of viral and bacterial infections, namely, hepatitis A, inflammatory diseases, namely, inflammatory bowel diseases, inflammatory connective tissue diseases, blood disorders, nutritional disorders, namely, mineral deficiency and toxicity, obesity, metabolic syndrome, under nutrition, vitamin deficiency, dependency and toxicity, immunological diseases, namely, autoimmune diseases, immunologic deficiency syndromes, dermatological disorders, namely, dermatitis, skin pigmentation diseases, sexually transmitted diseases, genetic disorders, namely, lysosomal storage diseases, mucopolysaccharidoses, phenylketonuria, alpha-mannosidosis, cystic fibrosis and muscular dystrophy, neurodegenerative diseases, namely, anxiety, depression, sleep disorders, chronic fatigue, schizophrenia, epilepsy, viral diseases, namely, herpes, hepatitis, Acquired Immune Deficiency Syndrome (AIDS), and infectious diseases, namely, respiratory infections, eye infections, antiparasites, cancer, obesity and diabetes in humans. ... Class 039 Transportation & Storage Services Transport and delivery of goods by air, truck, water. Class 040 Treatment & Processing of Materials Services Treatment of materials for the manufacturing of biotechnological pharmaceuticals and pharmaceuticals. Class 044 Medical, Beauty & Agricultural Services Pharmaceutical advice.
GENORA G.D. SEARLE & CO. (A DELAWARE CORPORATION) 574521 10 Dec 1986	ABANDONED SECTION 40(3) on 25 Feb 1998	Pharmaceutical preparations, namely oral contraceptives. Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations, namely oral contraceptives.

REGISTERED

on 18 Oct 2023

GENORA

S.P.H. - GERARD BERTRAND

2149699 · 5 Oct 2021

033

Vins.

REGISTERED

on 8 Feb 2023

GENORUM

FUMEI SHEN

2039802 · 15 Jul 2020

025

Ballet slippers; bath slippers; dress shoes; gloves; hats; leather sli...

REGISTERED

on 28 Feb 2013

GENOR

GENOR BIOPHARMA CO. LTD.

1444812 · 15 Jul 2009

001

005

Class 005

Pharmaceutical Products

Biological preparations for pharmaceutical purposes for the treatment of hepatitis A, inflammatory diseases, namely, inflammatory bowel diseases, inflammatory connective tissue diseases, blood disorders, nutritional disorders, namely, mineral deficiency and toxicity, obesity, metabolic syndrome, under nutrition, vitamin deficiency, dependency and toxicity, immunological diseases, namely, autoimmune diseases, immunologic deficiency syndromes, dermatological disorders, namely, dermatitis, skin pigmentation diseases, sexually transmitted diseases, genetic disorders, namely, lysosomal storage diseases, mucopolysaccharidoses, phenylketonuria, alpha-mannosidosis, cystic fibrosis and muscular dystrophy, neurodegenerative diseases, namely, anxiety, depression, sleep disorders, chronic fatigue, schizophrenia, epilepsy, viral diseases, namely, herpes, hepatitis, Acquired Immune Deficiency Syndrome (AIDS), and infectious diseases, namely, respiratory infections, eye infections, antiparasites, cancer, obesity and diabetes in humans; sanitary preparations for medical use in the treatment of hepatitis A, inflammatory diseases, namely, inflammatory bowel diseases, inflammatory connective tissue diseases, blood disorders, nutritional disorders, namely, mineral deficiency and toxicity, obesity, metabolic syndrome, under nutrition, vitamin deficiency, dependency and toxicity, immunological diseases, namely, autoimmune diseases, immunologic deficiency syndromes, dermatological disorders, namely, dermatitis, skin pigmentation diseases, sexually transmitted diseases, genetic disorders, namely, lysosomal storage diseases, mucopolysaccharidoses, phenylketonuria, alpha-mannosidosis, cystic fibrosis and muscular dystrophy, neurodegenerative diseases, namely, anxiety, depression, sleep disorders, chronic fatigue, schizophrenia, epilepsy, viral diseases, namely, herpes, hepatitis, Acquired Immune Deficiency Syndrome (AIDS), and infectious diseases, namely, respiratory infections, eye infections, antiparasites, cancer, obesity and diabetes in humans; medicines for treatment of viral and bacterial infections, namely, hepatitis A, inflammatory diseases, namely, inflammatory bowel diseases, inflammatory connective tissue diseases, blood disorders, nutritional disorders, namely, mineral deficiency and toxicity, obesity, metabolic syndrome, under nutrition, vitamin deficiency, dependency and toxicity, immunological diseases, namely, autoimmune diseases, immunologic deficiency syndromes, dermatological disorders, namely, dermatitis, skin pigmentation diseases, sexually transmitted diseases, genetic disorders, namely, lysosomal storage diseases, mucopolysaccharidoses, phenylketonuria, alpha-mannosidosis, cystic fibrosis and muscular dystrophy, neurodegenerative diseases, namely, anxiety, depression, sleep disorders, chronic fatigue, schizophrenia, epilepsy, viral diseases, namely, herpes, hepatitis, Acquired Immune Deficiency Syndrome (AIDS), and infectious diseases, namely, respiratory infections, eye infections, antiparasites, cancer, obesity and diabetes in humans; active pharmaceutical ingredients for the treatment of viral and bacterial infections, namely, hepatitis A, inflammatory diseases, namely, inflammatory bowel diseases, inflammatory connective tissue diseases, blood disorders, nutritional disorders, namely, mineral deficiency and toxicity, obesity, metabolic syndrome, under nutrition, vitamin deficiency, dependency and toxicity, immunological diseases, namely, autoimmune diseases, immunologic deficiency syndromes, dermatological disorders, namely, dermatitis, skin pigmentation diseases, sexually transmitted diseases, genetic disorders, namely, lysosomal storage diseases, mucopolysaccharidoses, phenylketonuria, alpha-mannosidosis, cystic fibrosis and muscular dystrophy, neurodegenerative diseases, namely, anxiety, depression, sleep disorders, chronic fatigue, schizophrenia, epilepsy, viral diseases, namely, herpes, hepatitis, Acquired Immune Deficiency Syndrome (AIDS), and infectious diseases, namely, respiratory infections, eye infections, antiparasites, cancer, obesity and diabetes in humans; biological substances and preparations for medical use and purposed for the treatment of viral and bacterial infections, namely, hepatitis A, inflammatory diseases, namely, inflammatory bowel diseases, inflammatory connective tissue diseases, blood disorders, nutritional disorders, namely, mineral deficiency and toxicity, obesity, metabolic syndrome, under nutrition, vitamin deficiency, dependency and toxicity, immunological diseases, namely, autoimmune diseases, immunologic deficiency syndromes, dermatological disorders, namely, dermatitis, skin pigmentation diseases, sexually transmitted diseases, genetic disorders, namely, lysosomal storage diseases, mucopolysaccharidoses, phenylketonuria, alpha-mannosidosis, cystic fibrosis and muscular dystrophy, neurodegenerative diseases, namely, anxiety, depression, sleep disorders, chronic fatigue, schizophrenia, epilepsy, viral diseases, namely, herpes, hepatitis, Acquired Immune Deficiency Syndrome (AIDS), and infectious diseases, namely, respiratory infections, eye infections, antiparasites, cancer, obesity and diabetes in humans; human vaccines; monoclonal antibodies; recombinant pharmaceuticals for the treatment of viral and bacterial infections, namely, hepatitis A, inflammatory diseases, namely, inflammatory bowel diseases, inflammatory connective tissue diseases, blood disorders, nutritional disorders, namely, mineral deficiency and toxicity, obesity, metabolic syndrome, under nutrition, vitamin deficiency, dependency and toxicity, immunological diseases, namely, autoimmune diseases, immunologic deficiency syndromes, dermatological disorders, namely, dermatitis, skin pigmentation diseases, sexually transmitted diseases, genetic disorders, namely, lysosomal storage diseases, mucopolysaccharidoses, phenylketonuria, alpha-mannosidosis, cystic fibrosis and muscular dystrophy, neurodegenerative diseases, namely, anxiety, depression, sleep disorders, chronic fatigue, schizophrenia, epilepsy, viral diseases, namely, herpes, hepatitis, Acquired Immune Deficiency Syndrome (AIDS), and infectious diseases, namely, respiratory infections, eye infections, antiparasites, cancer, obesity and diabetes in humans; protein for use as an additive for medical/pharmaceutical preparations for human consumption [adapted for medical purposes] for the treatment of viral and bacterial infections, namely, hepatitis A, inflammatory diseases, namely, inflammatory bowel diseases, inflammatory connective tissue diseases, blood disorders, nutritional disorders, namely, mineral deficiency and toxicity, obesity, metabolic syndrome, under nutrition, vitamin deficiency, dependency and toxicity, immunological diseases, namely, autoimmune diseases, immunologic deficiency syndromes, dermatological disorders, namely, dermatitis, skin pigmentation diseases, sexually transmitted diseases, genetic disorders, namely, lysosomal storage diseases, mucopolysaccharidoses, phenylketonuria, alpha-mannosidosis, cystic fibrosis and muscular dystrophy, neurodegenerative diseases, namely, anxiety, depression, sleep disorders, chronic fatigue, schizophrenia, epilepsy, viral diseases, namely, herpes, hepatitis, Acquired Immune Deficiency Syndrome (AIDS), and infectious diseases, namely, respiratory infections, eye infections, antiparasites, cancer, obesity and diabetes in humans; and biotechnological preparations for medical use for the treatment of viral and bacterial infections, namely, hepatitis A, inflammatory diseases, namely, inflammatory bowel diseases, inflammatory connective tissue diseases, blood disorders, nutritional disorders, namely, mineral deficiency and toxicity, obesity, metabolic syndrome, under nutrition, vitamin deficiency, dependency and toxicity, immunological diseases, namely, autoimmune diseases, immunologic deficiency syndromes, dermatological disorders, namely, dermatitis, skin pigmentation diseases, sexually transmitted diseases, genetic disorders, namely, lysosomal storage diseases, mucopolysaccharidoses, phenylketonuria, alpha-mannosidosis, cystic fibrosis and muscular dystrophy, neurodegenerative diseases, namely, anxiety, depression, sleep disorders, chronic fatigue, schizophrenia, epilepsy, viral diseases, namely, herpes, hepatitis, Acquired Immune Deficiency Syndrome (AIDS), and infectious diseases, namely, respiratory infections, eye infections, antiparasites, cancer, obesity and diabetes in humans.

...

Pharmaceutical advice.,Treatment of materials for the manufacturing of...

ABANDONED SECTION 40(3)

on 25 Feb 1998

GENORA

G.D. SEARLE & CO. (A DELAWARE CORPORATION)

574521 · 10 Dec 1986

005

Pharmaceutical preparations, namely oral contraceptives.

Owners

Fumei shen (1)

G.D. searle & co. (a delaware corporation) (1)

Genor biopharma co. ltd. (1)

S.P.H. - gerard bertrand (1)

Categories

Class 5 (2)

Class 1 (1)

Class 25 (1)

Class 33 (1)

Class 39 (1)

Class 40 (1)

Class 44 (1)

Correspondents

Anita mar (1)

Bcf s.E.N.C.R.L./bcf llp (1)

Borden ladner gervais llp (1)

Osler, hoskin & harcourt llp (1)

Display

List View

Grid View

Apply for Trademark

Select countries to protect your logo trademark

Trademark Name

Country Selected

Canada

$599 / 1 class + gov fee

United States

$99 / 1 class + gov fee

Canada

$599 / 1 class + gov fee

Mexico

$499 / 1 class + gov fee

European Union

$700 / 1 class + gov fee

China

$499 / 1 class + gov fee

South Korea

$699 / 1 class + gov fee

Japan

$799 / 1 class + gov fee

India

$99 / 1 class + gov fee

United Kingdom

$499 / 1 class + gov fee

Australia

$299 / 1 class + gov fee

Israel

$699 / 1 class + gov fee

United Arab Emirates

$699 / 1 class + gov fee

New Zealand

$699 / 1 class + gov fee

Brazil

$499 / 1 class + gov fee

Taiwan

$799 / 1 class + gov fee

Ukraine

$799 / 1 class + gov fee

Indonesia

$699 / 1 class + gov fee

South Africa

$499 / 1 class + gov fee

Singapore

$799 / 1 class + gov fee

Saudi Arabia

$799 / 1 class + gov fee

Afghanistan

$799 / 1 class + gov fee

Algeria

$799 / 1 class + gov fee

Argentina

$399 / 1 class + gov fee

Austria

$899 / 1 class + gov fee

Bahrain

$699 / 1 class + gov fee

Bangladesh

$599 / 1 class + gov fee

Benelux

$999 / 1 class + gov fee

Bhutan

$899 / 1 class + gov fee

Bolivia

$799 / 1 class + gov fee

Botswana

$1299 / 1 class + gov fee

British Virgin Islands

$1199 / 1 class + gov fee

Bulgaria

$799 / 1 class + gov fee

Cambodia

$799 / 1 class + gov fee

Chile

$499 / 1 class + gov fee

Colombia

$699 / 1 class + gov fee

Congo

$1199 / 1 class + gov fee

Costa Rica

$899 / 1 class + gov fee

Croatia

$899 / 1 class + gov fee

Cyprus

$999 / 1 class + gov fee

Czech Republic

$899 / 1 class + gov fee

Denmark

$799 / 1 class + gov fee

Dominican Republic

$899 / 1 class + gov fee

Ecuador

$799 / 1 class + gov fee

Egypt

$699 / 1 class + gov fee

El Salvador

$799 / 1 class + gov fee

Ethiopia

$1099 / 1 class + gov fee

France

$899 / 1 class + gov fee

Gaza

$799 / 1 class + gov fee

Germany

$899 / 1 class + gov fee

Greece

$799 / 1 class + gov fee

Guatemala

$899 / 1 class + gov fee

Haiti

$899 / 1 class + gov fee

Honduras

$899 / 1 class + gov fee

Hong Kong (SAR)

$899 / 1 class + gov fee

Hungary

$1099 / 1 class + gov fee

Iraq

$1499 / 1 class + gov fee

Italy

$899 / 1 class + gov fee

Jordan

$799 / 1 class + gov fee

Kazakhstan

$799 / 1 class + gov fee

Kenya

$899 / 1 class + gov fee

Kuwait

$799 / 1 class + gov fee

Laos

$699 / 1 class + gov fee

Lebanon

$999 / 1 class + gov fee

Lesotho

$1199 / 1 class + gov fee

Libya

$899 / 1 class + gov fee

Madrid Protocol (WIPO)

$1999 / 1 class + gov fee

Malawi

$1099 / 1 class + gov fee

Malaysia

$699 / 1 class + gov fee

Maldives

$999 / 1 class + gov fee

Morocco

$999 / 1 class + gov fee

Mozambique

$899 / 1 class + gov fee

Myanmar

$799 / 1 class + gov fee

Namibia

$799 / 1 class + gov fee

Nepal

$699 / 1 class + gov fee

Nicaragua

$899 / 1 class + gov fee

Norway

$899 / 1 class + gov fee

Oman

$1099 / 1 class + gov fee

Pakistan

$799 / 1 class + gov fee

Panama

$899 / 1 class + gov fee

Paraguay

$899 / 1 class + gov fee

Peru

$799 / 1 class + gov fee

Philippines

$899 / 1 class + gov fee

Poland

$499 / 1 class + gov fee

Portugal

$899 / 1 class + gov fee

Puerto Rico

$899 / 1 class + gov fee

Qatar

$799 / 1 class + gov fee

Romania

$899 / 1 class + gov fee

Serbia

$899 / 1 class + gov fee

Slovakia

$899 / 1 class + gov fee

Spain

$899 / 1 class + gov fee

Sri Lanka

$699 / 1 class + gov fee

Swaziland

$1299 / 1 class + gov fee

Sweden

$799 / 1 class + gov fee

Switzerland

$899 / 1 class + gov fee

Thailand

$799 / 1 class + gov fee

Tunisia

$899 / 1 class + gov fee

Turkey

$799 / 1 class + gov fee

Uganda

$699 / 1 class + gov fee

United Republic of Tanzania

$699 / 1 class + gov fee

Uruguay

$799 / 1 class + gov fee

Venezuela

$899 / 1 class + gov fee

Vietnam

$799 / 1 class + gov fee

West Bank, Palestine

$799 / 1 class + gov fee

Yemen

$1699 / 1 class + gov fee

Albania

$899 / 1 class + gov fee

Andorra

$899 / 1 class + gov fee

Angola

$1299 / 1 class + gov fee

Antigua and Barbuda

$1299 / 1 class + gov fee

Armenia

$799 / 1 class + gov fee

Azerbaijan

$799 / 1 class + gov fee

Bahamas

$1399 / 1 class + gov fee

Barbados

$1299 / 1 class + gov fee

Belgium

$999 / 1 class + gov fee

Belize

$1299 / 1 class + gov fee

Benin

$799 / 1 class + gov fee

Bosnia and Herzegovina

$999 / 1 class + gov fee

Brunei

$1299 / 1 class + gov fee

Burkina Faso

$799 / 1 class + gov fee

Burundi

$1199 / 1 class + gov fee

Cabo Verde

$899 / 1 class + gov fee

Cameroon

$799 / 1 class + gov fee

Central African Republic (CAR)

$799 / 1 class + gov fee

Chad

$799 / 1 class + gov fee

Comoros

$799 / 1 class + gov fee

Cote d'Ivoire

$799 / 1 class + gov fee

Czechia

$999 / 1 class + gov fee

Djibouti

$1199 / 1 class + gov fee

Dominica

$1299 / 1 class + gov fee

Equatorial Guinea

$799 / 1 class + gov fee

Eritrea

$999 / 1 class + gov fee

Estonia

$1299 / 1 class + gov fee

Eswatini

$1299 / 1 class + gov fee

Fiji

$899 / 1 class + gov fee

Finland

$699 / 1 class + gov fee

Gabon

$799 / 1 class + gov fee

Gambia

$899 / 1 class + gov fee

Georgia

$799 / 1 class + gov fee

Ghana

$999 / 1 class + gov fee

Grenada

$1299 / 1 class + gov fee

Guinea

$799 / 1 class + gov fee

Guinea-Bissau

$799 / 1 class + gov fee

Guyana

$1299 / 1 class + gov fee

Iceland

$1299 / 1 class + gov fee

Ireland

$899 / 1 class + gov fee

Jamaica

$1199 / 1 class + gov fee

Kiribati

$999 / 1 class + gov fee

Kosovo

$899 / 1 class + gov fee

Kyrgyzstan

$899 / 1 class + gov fee

Latvia

$699 / 1 class + gov fee

Liberia

$999 / 1 class + gov fee

Liechtenstein

$999 / 1 class + gov fee

Lithuania

$699 / 1 class + gov fee

Luxembourg

$999 / 1 class + gov fee

Madagascar

$999 / 1 class + gov fee

Mali

$799 / 1 class + gov fee

Malta

$599 / 1 class + gov fee

Marshall Islands

$999 / 1 class + gov fee

Mauritania

$799 / 1 class + gov fee

Mauritius

$899 / 1 class + gov fee

Micronesia

$999 / 1 class + gov fee

Moldova

$999 / 1 class + gov fee

Monaco

$1399 / 1 class + gov fee

Mongolia

$599 / 1 class + gov fee

Montenegro

$899 / 1 class + gov fee

Nauru

$999 / 1 class + gov fee

Netherlands

$999 / 1 class + gov fee

Niger

$799 / 1 class + gov fee

Nigeria

$399 / 1 class + gov fee

North Macedonia

$899 / 1 class + gov fee

Palau

$999 / 1 class + gov fee

Palestine

$999 / 1 class + gov fee

Papua New Guinea

$799 / 1 class + gov fee

Rwanda

$999 / 1 class + gov fee

Saint Kitts and Nevis

$1299 / 1 class + gov fee

Saint Lucia

$1299 / 1 class + gov fee

Saint Vincent and the Grenadines

$1299 / 1 class + gov fee

Samoa

$1199 / 1 class + gov fee

San Marino

$999 / 1 class + gov fee

Sao Tome and Principe

$999 / 1 class + gov fee

Senegal

$799 / 1 class + gov fee

Seychelles

$999 / 1 class + gov fee

Sierra Leone

$999 / 1 class + gov fee

Slovenia

$899 / 1 class + gov fee

Solomon Islands

$999 / 1 class + gov fee

Somalia

$999 / 1 class + gov fee

South Sudan

$999 / 1 class + gov fee

Suriname

$1599 / 1 class + gov fee

Tajikistan

$799 / 1 class + gov fee

Tanzania

$699 / 1 class + gov fee

Timor-Leste

$999 / 1 class + gov fee

Togo

$799 / 1 class + gov fee

Tonga

$1299 / 1 class + gov fee

Trinidad and Tobago

$1399 / 1 class + gov fee

Turkmenistan

$799 / 1 class + gov fee

Tuvalu

$999 / 1 class + gov fee

Uzbekistan

$699 / 1 class + gov fee

Vanuatu

$1199 / 1 class + gov fee

Zambia

$899 / 1 class + gov fee

Zimbabwe

$899 / 1 class + gov fee

OAPI

$899 / 1 class + gov fee

ARIPO

$999 / 1 class + gov fee

End of search results

Page 1 of 1